Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.4M Buy
206,068
+201,918
+4,865% +$21.7M 0.04% 379
2026
Q1
$425K Buy
+4,150
New +$423K ﹤0.01% 2921
2025
Q2
Sell
-3,884
Closed -$275K 3607
2025
Q1
$275K Sell
3,884
-42,379
-92% -$3.31M ﹤0.01% 2649
2024
Q4
$3.62M Buy
+46,263
New +$4.32M 0.01% 873
2024
Q3
Sell
-12,788
Closed -$970K 2985
2024
Q2
$970K Sell
12,788
-20,254
-61% -$1.44M 0.01% 1475
2024
Q1
$2.48M Buy
33,042
+3,864
+13% +$308K 0.02% 919
2023
Q4
$2.15M Buy
29,178
+9,670
+50% +$598K 0.02% 1050
2023
Q3
$897K Sell
19,508
-6,172
-24% -$274K 0.01% 1358
2023
Q2
$1.08M Buy
25,680
+16,932
+194% +$640K 0.01% 1266
2023
Q1
$228K Buy
+8,748
New +$259K ﹤0.01% 2104

Other funds holding NUVL

Paul Tudor Jones's NUVL Position: Q2 2026 in Review

Paul Tudor Jones increased its Nuvalent (NUVL) stake by 4,865% in Q2 2026, buying an estimated $21.7M and bringing the position to 206,068 shares worth $25.4M. The position accounts for 0.04% of the portfolio, ranked #379.

Paul Tudor Jones first reported a position in NUVL in Q1 2023 and has held it in 10 quarters since. 287 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Paul Tudor Jones held 206,068 shares of Nuvalent worth $25.4M as of Q2 2026.
  • Paul Tudor Jones bought 201,918 Nuvalent shares in Q2 2026, an estimated $21.7M.
  • Nuvalent made up 0.04% of Paul Tudor Jones's portfolio in Q2 2026, its #379 holding.
  • Paul Tudor Jones first reported a position in Nuvalent in Q1 2023 and has held it in 10 quarters since.
  • 287 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.